相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Motor axon excitability during Wallerian degeneration
Mihai Moldovan et al.
BRAIN (2009)
About the role of visual field defects in pure alexia
Tobias Pflugshaupt et al.
BRAIN (2009)
Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced Neurotoxicity
Susanna B. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CONDUCTION BLOCK AND IMPAIRED AXONAL FUNCTION IN TICK PARALYSIS
Arun V. Krishnan et al.
MUSCLE & NERVE (2009)
Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies
S. B. Park et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Assessment of nerve excitability in toxic and metabolic neuropathies
Arun V. Krishnan et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2007)
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07
Stephanie R. Land et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients
Wei-Shu Wang et al.
ONCOLOGIST (2007)
Axonal conduction and injury in multiple sclerosis: the role of sodium channels
Stephen G. Waxman
NATURE REVIEWS NEUROSCIENCE (2006)
Oxaliplatin and axonal Na+ channel function in vivo
Arun V. Krishnan et al.
CLINICAL CANCER RESEARCH (2006)
Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up
Alberto Pietrangeli et al.
EUROPEAN NEUROLOGY (2006)
The pathophysiology of oxaliplatin-induced neurotoxicity
Matthew C. Kiernan et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels
RG Webster et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability
MC Kiernan et al.
BRAIN (2005)
Oxaliplatin-induced neurotoxicity and the development of neuropathy
AV Krishnan et al.
MUSCLE & NERVE (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish
MC Kiernan et al.
ANNALS OF NEUROLOGY (2005)
The effects of mexiletine on excitability properties of human median motor axons
S Kuwabara et al.
CLINICAL NEUROPHYSIOLOGY (2005)
Oxaliplatin-induced neurotoxicity: Acute hyperexcitability and chronic neuropathy
RJ Lehky et al.
MUSCLE & NERVE (2004)
Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans
M Bouhours et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions:: A retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer
L Gamelin et al.
CLINICAL CANCER RESEARCH (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mechanisms of hyperpolarization in regenerated mature motor axons in cat
M Moldovan et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
J Cassidy et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale
G Cavaletti et al.
NEUROLOGY (2003)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures
E Gamelin et al.
SEMINARS IN ONCOLOGY (2002)
Oxaliplatin-related side effects: Characteristics and management
J Cassidy et al.
SEMINARS IN ONCOLOGY (2002)
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial
S Cascinu et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Phenotypic variants of autoimmune peripheral nerve hyperexcitability
Ian K. Hart et al.
BRAIN (2002)
Acute oxaliplatin-induced peripheral nerve hyperexcitability
RH Wilson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Excitability of human axons
D Burke et al.
CLINICAL NEUROPHYSIOLOGY (2001)
Effects of temperature on neuromuscular electrophysiology
SB Rutkove
MUSCLE & NERVE (2001)
Voluntary contraction impairs the refractory period of transmission in healthy human axons
S Kuwabara et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Excitability properties of motor axons in patients with spontaneous motor unit activity
MC Kiernan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Effects of membrane polarization and ischaemia on the excitability properties of human motor axons
MC Kiernan et al.
BRAIN (2000)
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
H Adelsberger et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Grading of chemotherapy-induced peripheral neuropathy
TJ Postma et al.
ANNALS OF ONCOLOGY (2000)
分享论文
